作者
Pallawi Torka,Tatyana Feldman,Kerry J. Savage,Nivetha Ganesan,Esther Drill,Helen Hancock,Theresa Davey,Leslie Perez,Charisse Capadona,Sarima Subzwari,Natasha Galasso,Jin‐Shu Yang,Michael L. Post,Alexander P. Boardman,Philip Caron,Kevin A. David,Zachary D. Epstein‐Peterson,Lorenzo Falchi,Paola Ghione,Paul A. Hamlin,Steven M. Horwitz,Andrew M. Intlekofer,W. Thomas Johnson,Anita Kumar,Jennifer Kimberly Lue,Ariela Noy,Colette Owens,M. Lia Palomba,Gilles Salles,Raphaël Steiner,Robert Stuver,Santosha A. Vardhana,Joachim Yahalom,Ahmet Doǧan,Andrew D. Zelenetz,Heiko Schöder,Alison J. Moskowitz
摘要
We conducted a phase I/II study evaluating nivolumab plus doxorubicin, vinblastine, dacarbazine (N-AVD) as frontline therapy for treatment-naïve older adults (OA) with classical Hodgkin lymphoma (cHL; ClinicalTrials.gov identifier: NCT03033914).
劲秉
不配.
杳鸢
坚强的广山
VDC
mss12138
嗯哼
Darcy
jyy
乐乐乐乐乐乐
彭于彦祖
pluto
iNk
吃不饱星球球长
殷勤的紫槐
寻道图强
柳叶刀小猪
tuanheqi
宜醉宜游宜睡
不懈奋进
皖公网安备34019202002308
